Classification system legal status of supply NSAIDs
The classification system for the legal status of supply of NSAIDs is determined by the Medicines Evaluation Board (MEB). There are 3 determining factors: the active substance, the dosage and the package size.
The classification system is determined using the level of the active substances and is based on the latest scientific insights. Of the anti-inflammatories studied, the MEB notes that the dosage, both each time and per day, is the key factor in reducing the risks of side effects and interactions with other medicinal products. Additionally, the MEB aims to minimise possible health risks by limiting the package size.
In 2009, the MEB determined a classification system for NSAIDs and aspirin. In the period thereafter, various other decisions were made relating to combination preparations containing NSAIDs, new strengths and new pharmaceutical forms.